Encompass Health (NYSE:EHC) Given “Outperform” Rating at Credit Suisse Group

Credit Suisse Group reaffirmed their outperform rating on shares of Encompass Health (NYSE:EHC) in a report released on Friday, March 16th. Credit Suisse Group currently has a $65.00 target price on the stock, up from their previous target price of $61.00.

A number of other brokerages have also recently commented on EHC. Piper Jaffray restated a hold rating on shares of Encompass Health in a research report on Thursday, March 1st. Bank of America upgraded Encompass Health from an underperform rating to a neutral rating in a research report on Thursday, January 4th. Craig Hallum reaffirmed a buy rating and issued a $60.00 price objective (up from $54.00) on shares of Encompass Health in a research note on Tuesday, January 9th. Finally, ValuEngine raised Encompass Health from a hold rating to a buy rating in a research note on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of $62.33.

How to Become a New Pot Stock Millionaire

EHC stock traded down $1.42 during trading hours on Friday, hitting $57.58. 534,303 shares of the stock were exchanged, compared to its average volume of 606,265. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.36 and a quick ratio of 1.36. Encompass Health has a 12 month low of $42.21 and a 12 month high of $59.70. The stock has a market capitalization of $5,650.84, a price-to-earnings ratio of 20.86, a PEG ratio of 1.30 and a beta of 0.38.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, February 26th. The company reported $0.70 EPS for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. Encompass Health had a return on equity of 20.59% and a net margin of 6.45%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1 billion. research analysts expect that Encompass Health will post 3.36 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Monday, April 2nd will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.74%. The ex-dividend date is Thursday, March 29th. Encompass Health’s dividend payout ratio (DPR) is presently 36.23%.

COPYRIGHT VIOLATION NOTICE: “Encompass Health (NYSE:EHC) Given “Outperform” Rating at Credit Suisse Group” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/08/encompass-health-ehc-stock-rating-reaffirmed-by-credit-suisse-group-2.html.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply